Hayvan Sağlığı Araştırmaları 2009 Yılı Program - Tagem

�����������������
1. Amadori, M., Archetti, I.L., Tollis, M. (1991): Potency assesment of FMDV vaccines in cattle
by means of antibody assays. Biological, 191-196.
2. Anderson, E. C., Doughty, W. J., Muthiani, A. (1983): Observations on the stability of foot and
mouth disease vaccine antigens. Vaccine Dec. 1(1),26-30.
3. Bahnemann, H.G. (1975): Binary ethylenimine as an inactivant for FMD virus and its
application for vaccine production. Arch. Virol. 47-1, 47-56.
4. Barnett, P.V. and Doel, T.R. (1992): Stability and potency studies with FMD vaccines prepared
from antigens stored in the Pirbright bank: Comparisons between oil and Al(OH)3 formulations
Europ Comm. of the Cont. of FMD. Sess. of the Reac. Grp. of the Stan. Tech. Comm., Berne. 25-
29.
5. Barteling, S.J., Cassim, N.I. (2000): Formaldehyde enhances BEI-inactivation rates of foot-andmouth
disease (FMD) virus by at least a ten-fold, In: Report ; European Commission for the
Control of Foot-and-Mouth Disease. Research Group of the Standing Technical Committee,
Borovets (Bulgaria), / FAO, Rome (Italy). Animal Production and Health Div., 270-275.
6. Barteling, S.J., Meloen. R.H. (1974): A simple method for the qualification of 146 S particules
of FMDV. Arch. Ges. Virus forch . 45, 362-364.
7. Bartelling, S.J., Swam, H., Anemaet, D.A.S., Tuyn, C., and Vreeswijk, J. (1996): Foot-and-
Mouth Disease (FMD) vaccines based on antigens from the European Vaccine Bank are very
potent. European Commission for the control of FMD., 85-90.
8. Barteling, S.J., and Vreeswijk, J. (1991): Developments in foot and mouth disease vaccines.
Vaccine, Vol 9, 75-88.
������������������������������������������������������������������������������������������������
����������� �������� �������������� ����������� ������������� �������� �������� ������������ ����� ������
Dergisi, Seri D, 9(2): 131-143
10. Castro M. G., Windeatt S., and Perone M. J.(2008): Control of Proteolysis in Cell Culture: Use
of Inhibitors and Engineered Cell Lines. Methods in Biotechnology Vol 8, 263-275
11. Cowman R.A., Speck M.L., 1965. Ultra-low temperature storage of lactic streptococci.
J.Dairy Sci.48(11):1531-2
12. Dekker, A., Terpstra, Bartelling, S.J. (1992): Antibody kinetics and protection after challenge
of foot and mouth disease vaccines formulated from stored antigen., Rep.Sess. Res. Group Eur.
Comm. Contr. FMD, Mittelhaüsern, pp 23-34.
13. Doel TR, Baccarini P.J. (1981): Thermal stability of foot-and-mouth disease virus. Arch
Virol.;70 (1), 21-32.
14. Doel, T. R., Collen, T. (1982): Qualitative assessment of 146S particles of FMDV in
preparations destined for vaccines. J. Biol. Stand.. 10, 69-81.
15. Doel, T. R. David, D. J. (1984): The stability and potency of vaccines prepared from
inactivated foot-and-mouth disease virus concentrates J. Biol. Stand 12, 247-255.
16. Doel, T.R., Pullen, L. (1990): International bank for foot-and-mouth disease vaccine: stability
studies with virus J. Biol. Stand. 10, 185-195.
17. Dudnikov, A.I., Mikhalishin, V.V., Gusev, A.A., Ulupov, N.A., Mamkov, N.S., Polyakov,
O.N., Lezov, T.N. (1995): Immunological properties of inactivated FMD vaccine of new
generation. European Commission for the Control of Foot and Mouth Disease. Vladimir, Russian
Federation.
18. Dudnikov, A.I., Mikhalishin, V.V., Gusev, A.A., Ulupov, N.A., Mamkov, N.S., Zakharov,
V.M., Shipilov, V.I., Polyakov, O.N., Lezova, T.N., Nersesyan, S.E. (1995): Inactivated FMD
vaccine with new immunobiological characteristics produced at the All-Russian Research Institute
for Animal Health. Europen Commission for the Control of Foot and Mouth Disease. Vladimir,
Russian Federation.
19.Gould E. A.,(1995). Virus cryopreservation and storage. Methods Mol Biol. ;38:7-20.
20. Grubman M. J., Baxt B. (2004): Foot-and Mouth Disease. Clinical microbiology Reviews, Vol
17, 465–493.
21. Hunter, P. (1996): The performense of SAT types of FMD antigen in oil adjuvant vaccines.
Scient, Technical Rev. OIE.
298